COMPASS Pathways plc (CMPS) Research

COMPASS Pathways plc is a mental healthcare company with a primary presence in the United Kingdom and the United States. Established in 2020 and headquartered in London, UK, the firm focuses on developing novel treatments. Its key product is COMP360, an investigational psilocybin therapy. This therapy has advanced through Phase IIb clinical trials for treatment-resistant depression and is currently undergoing Phase II trials for post-traumatic stress disorder. The company previously operated under the name COMPASS Rx Limited before rebranding to COMPASS Pathways plc in August 2020.

Market snapshot

Symbol
CMPS
Price
$12.53
Day change
+4.94%
Market cap
$1.2B
P/E ratio
-7.71x
52-week range
2.25-14.76
Sector
Healthcare
Industry
Medical - Care Facilities
Next earnings
in 1 month
Analyst price target
$18.57

Recent news

  • Compass Pathways shares rise on Q1 results, accelerated FDA review

    Compass Pathways (NASDAQ:CMPS) shares rose 14% after it reported first quarter results that topped expectations and showed continued regulatory progress for its lead therapy COMP360 in treatment-resistant depression. For the quarter, Compass reported an adjusted loss of $0.30 per share, coming in ahead of analyst expectations of a loss per share of $0.43.

  • Compass Pathways shares rise on Q1 results, accelerated FDA review

    Compass Pathways (NASDAQ:CMPS) shares rose 14% after it reported first quarter results that topped expectations and showed continued regulatory progress for...

  • FTSE 100 Live: London stocks slide as aerospace and defence sector falls

    FTSE 100 down 35 points at 10,574 Markets await confirmation of US-Iran talks UK bond eyes developments in Westminster AB Foods, British Land,...

Peer companies

  • Avanos Medical, Inc. (AVNS)
  • Community Health Systems, Inc. (CYH)
  • Enhabit, Inc. (EHAB)
  • 4D Molecular Therapeutics, Inc. (FDMT)
  • Gossamer Bio, Inc. (GOSS)
  • KalVista Pharmaceuticals, Inc. (KALV)
  • Prothena Corporation plc (PRTA)
  • Sonida Senior Living, Inc. (SNDA)

Recent insider activity

  • Karydas Daphne — A-Award (21110 shares) on 2026-05-27
  • SANTINI GINO — A-Award (30158 shares) on 2026-05-27
  • Gover Justin D. — A-Award (21110 shares) on 2026-05-27
  • JONAS JEFFREY M — A-Award (21110 shares) on 2026-05-27
  • Riley Wayne Joseph — A-Award (21110 shares) on 2026-05-27

Open COMPASS Pathways plc (CMPS) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.